Title |
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
|
---|---|
Published in |
Supportive Care in Cancer, June 2015
|
DOI | 10.1007/s00520-015-2809-3 |
Pubmed ID | |
Authors |
Yolanda Escobar, Gerardo Cajaraville, Juan Antonio Virizuela, Rosa Álvarez, Andrés Muñoz, Olatz Olariaga, María José Tamés, Begoña Muros, María Jose Lecumberri, Jaime Feliu, Purificación Martínez, Juan Carlos Adansa, María José Martínez, Rafael López, Ana Blasco, Pere Gascón, Virginia Calvo, Pablo Luna, Joaquín Montalar, Patricia Del Barrio, María Victoria Tornamira |
Abstract |
This study aims to determine the incidence of nausea and vomiting (CINV) after moderately emetogenic chemotherapy (MEC), under medical practice conditions and the accuracy with which physicians perceive CINV. Chemotherapy-naive patients receiving MEC between April 2012 and May 2013 were included. Patients completed a diary of the intensity of nausea and number of vomiting episodes. Complete response and complete protection were assessed as secondary endpoints. Of 261 patients included, 240 were evaluated. Median age was 64 years, 44.2 % were female and 11.2 % were aged less than 50 years; 95.3 % of patients received a combination of 5-hydroxytryptamine 3 (5-HT3) antagonist + corticosteroid as antiemetic treatment. Vomiting within 5 days of chemotherapy administration occurred in 20.8 %, nausea in 42 % and significant nausea in 23.8 % of patients. An increase in the percentage of patients with significant nausea (from 9.4 to 21.7 %) and vomiting (from 9.2 to 16.5 %) was observed from the acute to the delayed phase. Complete response was 84.2 % in the acute phase, 77 % in the late phase and 68.9 % in overall period. Complete protection was 79.5 % in the acute phase, 68.8 % in the late phase and 62.4 % throughout the study period. Physicians estimated prophylaxis would be effective for 75 % of patients receiving MEC, compared with 54.1 % obtained from patients' diary. Despite receiving prophylactic treatment, 31 % of patients did not achieve a complete response and 38 % complete protection. In general, nausea was worse controlled than vomiting. The results also showed the late phase was worse controlled than the acute phase in all variables. Healthcare providers overestimated the effectiveness of antiemetic prophylaxis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Unknown | 109 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 14% |
Student > Bachelor | 14 | 13% |
Other | 13 | 12% |
Researcher | 7 | 6% |
Student > Postgraduate | 6 | 5% |
Other | 21 | 19% |
Unknown | 34 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 23% |
Nursing and Health Professions | 15 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 10% |
Biochemistry, Genetics and Molecular Biology | 8 | 7% |
Agricultural and Biological Sciences | 4 | 4% |
Other | 7 | 6% |
Unknown | 40 | 36% |